WEBSITE BSE:543210 NSE: AARTISURF Inc. Year: 2018 Industry: Household & Personal Products My Bucket: Add Stock
Last updated: 15:58
No Notes Added Yet
1. Business Overview
Aarti Surfactants Ltd. is an Indian specialty chemical manufacturer primarily engaged in the production and supply of a wide range of surfactants and other specialty chemicals. The company manufactures various anionic, cationic, non-ionic, and amphoteric surfactants. Its core business model involves developing, manufacturing, and selling these chemical ingredients to other businesses, which then use them in formulating finished consumer products. Aarti Surfactants makes money by supplying these critical raw materials to industries such as home care (detergents, dishwashers), personal care (shampoos, soaps, cosmetics), and industrial applications.
2. Key Segments / Revenue Mix
Aarti Surfactants Ltd. operates predominantly as a single business segment, focused on the manufacturing and sale of surfactants and specialty chemicals. While not explicitly broken down into distinct reporting segments, its product applications broadly cater to:
Personal Care: Ingredients for shampoos, body washes, soaps, cosmetics.
Home Care: Ingredients for laundry detergents, dishwashing liquids, floor cleaners.
Industrial Applications: Surfactants for various industrial processes.
The revenue mix is primarily driven by sales to these end-use industries, with personal care and home care sectors typically forming the largest proportion. Specific percentage contributions by application vary over time and are generally not reported as separate financial segments.
3. Industry & Positioning
Aarti Surfactants operates in the highly competitive Indian specialty chemicals industry, specifically within the surfactants segment for household and personal care. The industry is characterized by the need for technical expertise, consistent quality, and efficient manufacturing. It includes both large global players with integrated operations and smaller, specialized regional manufacturers. Aarti Surfactants positions itself as a key domestic supplier, focusing on a diverse product portfolio, custom formulations, and adherence to quality standards. Its competitive standing is built on its manufacturing capabilities and ability to cater to the specific needs of Indian and regional consumer product manufacturers, competing with both domestic and international chemical suppliers present in India.
4. Competitive Advantage (Moat)
Aarti Surfactants' competitive advantages include:
Formulation Expertise & R&D: The ability to develop and customize a wide array of surfactants to meet specific client requirements provides a degree of stickiness with customers.
Cost Efficiency: As a domestic manufacturer, it potentially benefits from localized raw material sourcing and manufacturing efficiencies, offering competitive pricing.
Customer Relationships & Integration: Long-standing relationships with key customers in the personal care and home care segments, often involving product co-development, can create switching costs.
Manufacturing Scale (Regional): Having dedicated manufacturing facilities for various surfactant types allows for some scale benefits within the Indian market.
5. Growth Drivers
Rising Disposable Incomes: Increasing affluence in India drives higher consumption of personal care and home care products, boosting demand for their raw materials.
Premiumization & Specialization: Growing consumer preference for specialized, milder, or sustainable products (e.g., sulphate-free shampoos, eco-friendly detergents) requires advanced surfactant formulations.
"Make in India" Push: Government initiatives promoting domestic manufacturing can encourage consumer goods companies to source raw materials locally.
Capacity Expansion: Any future planned expansions in manufacturing capacity can directly translate to higher sales volumes.
Export Opportunities: Tapping into international markets for specialty surfactants could provide additional growth avenues.
6. Risks
Raw Material Price Volatility: Surfactant manufacturing is dependent on petrochemical derivatives (e.g., oleochemicals, ethoxylates), whose prices are often linked to crude oil and agricultural commodity prices, leading to margin fluctuations.
Intense Competition: The presence of well-established domestic and international players can put pressure on pricing and market share.
Regulatory Changes: Evolving environmental regulations, chemical safety norms, or import/export policies can impact operations and costs.
Economic Slowdown: A downturn in consumer spending could reduce demand for end-products, consequently affecting demand for surfactants.
Technological Obsolescence: Failure to keep pace with new formulation trends or cleaner production technologies could erode competitiveness.
Customer Concentration: Dependence on a few large customers could expose the company to significant risks if those relationships deteriorate or their demand shifts.
7. Management & Ownership
Aarti Surfactants Ltd. is part of the Aarti Group, which has a significant presence in the Indian chemical industry. The company is promoted by the Gogri family, who are well-known entrepreneurs in the Indian chemical sector. The management team typically comprises experienced professionals with a strong background in chemistry and business management, often including members of the promoter family. The ownership structure generally features a substantial promoter holding, alongside institutional investors (mutual funds, FIIs) and public shareholders, reflecting confidence in the long-term vision of the founding family and their operational expertise in the chemical domain.
8. Outlook
Aarti Surfactants operates in a fundamentally growing market, driven by India's large and expanding consumer base for home and personal care products. The company benefits from its specialized product portfolio and established relationships with key clients. The ability to innovate and provide tailored solutions for evolving consumer preferences (e.g., eco-friendly, milder formulations) will be crucial for sustained growth. However, profitability remains susceptible to the volatility of raw material prices and intense competition, which necessitates continuous focus on operational efficiency and cost management. While the long-term demand for surfactants is positive, the company's performance will hinge on its agility in managing input costs, expanding capacity judiciously, and maintaining its technical edge in a dynamic chemical industry.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹330 Cr.
Stock P/E 22.7
P/B 1.3
Current Price ₹389.4
Book Value ₹ 289.3
Face Value 10
52W High ₹613
Dividend Yield 0.26%
52W Low ₹ 317.7
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 139 | 159 | 143 | 151 | 163 | 202 | 216 | 179 | 208 | 256 |
| Other Income | 0 | 0 | 0 | 2 | -0 | 1 | 0 | 0 | 0 | 0 |
| Total Income | 139 | 159 | 144 | 153 | 163 | 203 | 216 | 179 | 208 | 256 |
| Total Expenditure | 122 | 144 | 134 | 147 | 154 | 182 | 204 | 170 | 195 | 243 |
| Operating Profit | 17 | 14 | 10 | 6 | 9 | 21 | 12 | 9 | 13 | 13 |
| Interest | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Depreciation | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 9 | 7 | 3 | 3 | 1 | 13 | 4 | 2 | 5 | 6 |
| Provision for Tax | 2 | 2 | 1 | 1 | 0 | 3 | 1 | 1 | 1 | 2 |
| Profit After Tax | 7 | 5 | 2 | 2 | 1 | 10 | 3 | 2 | 4 | 4 |
| Adjustments | -0 | -0 | 0 | -0 | 0 | -0 | 0 | -0 | 0 | 0 |
| Profit After Adjustments | 7 | 5 | 2 | 2 | 1 | 10 | 3 | 2 | 4 | 4 |
| Adjusted Earnings Per Share | 8.4 | 5.5 | 2.6 | 2.1 | 0.9 | 11.5 | 3.5 | 1.8 | 4.3 | 4.9 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Net Sales | 326 | 466 | 576 | 601 | 590 | 659 | 859 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 3 | 0 |
| Total Income | 326 | 466 | 576 | 602 | 590 | 663 | 859 |
| Total Expenditure | 302 | 420 | 543 | 554 | 528 | 617 | 812 |
| Operating Profit | 24 | 46 | 32 | 48 | 62 | 45 | 47 |
| Interest | 10 | 10 | 11 | 15 | 14 | 12 | 12 |
| Depreciation | 11 | 12 | 12 | 15 | 16 | 17 | 16 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 4 | 0 |
| Profit Before Tax | 3 | 23 | 9 | 18 | 32 | 21 | 17 |
| Provision for Tax | 1 | 1 | 4 | 5 | 11 | 6 | 5 |
| Profit After Tax | 2 | 22 | 5 | 13 | 21 | 15 | 13 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 2 | 22 | 5 | 13 | 21 | 15 | 13 |
| Adjusted Earnings Per Share | 2.7 | 28.1 | 7.1 | 16 | 25.2 | 17.2 | 14.5 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 12% | 5% | 15% | 0% |
| Operating Profit CAGR | -27% | 12% | 13% | 0% |
| PAT CAGR | -29% | 44% | 50% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -37% | -14% | -23% | NA% |
| ROE Average | 6% | 9% | 10% | 8% |
| ROCE Average | 10% | 12% | 11% | 10% |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Shareholder's Funds | 111 | 133 | 136 | 168 | 218 | 233 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 49 | 80 | 105 | 73 | 48 | 28 |
| Other Non-Current Liabilities | 8 | 9 | 12 | 20 | 27 | 31 |
| Total Current Liabilities | 95 | 164 | 149 | 142 | 129 | 186 |
| Total Liabilities | 262 | 387 | 402 | 404 | 422 | 477 |
| Fixed Assets | 151 | 187 | 173 | 207 | 209 | 204 |
| Other Non-Current Assets | 17 | 24 | 55 | 14 | 14 | 21 |
| Total Current Assets | 94 | 175 | 175 | 182 | 199 | 252 |
| Total Assets | 262 | 387 | 402 | 404 | 422 | 477 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 7 | 1 | 8 | 6 |
| Cash Flow from Operating Activities | 18 | 36 | 23 | 25 | 52 | 11 |
| Cash Flow from Investing Activities | -2 | -60 | -23 | -11 | -16 | -16 |
| Cash Flow from Financing Activities | -16 | 32 | -6 | -8 | -37 | -0 |
| Net Cash Inflow / Outflow | 0 | 7 | -5 | 6 | -1 | -5 |
| Closing Cash & Cash Equivalent | 0 | 7 | 1 | 8 | 6 | 1 |
| # | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 2.71 | 28.1 | 7.14 | 16 | 25.19 | 17.2 |
| CEPS(Rs) | 16.44 | 43.95 | 23.3 | 35.5 | 44.14 | 37.7 |
| DPS(Rs) | 0 | 3 | 0 | 0 | 0 | 1 |
| Book NAV/Share(Rs) | 144.08 | 172.27 | 176.51 | 211.58 | 257.64 | 274.8 |
| Core EBITDA Margin(%) | 7.24 | 9.77 | 5.58 | 7.94 | 10.53 | 6.36 |
| EBIT Margin(%) | 4.06 | 7.16 | 3.47 | 5.42 | 7.84 | 4.89 |
| Pre Tax Margin(%) | 0.9 | 4.92 | 1.62 | 2.96 | 5.46 | 3.14 |
| PAT Margin (%) | 0.64 | 4.64 | 0.95 | 2.11 | 3.62 | 2.21 |
| Cash Profit Margin (%) | 3.89 | 7.27 | 3.12 | 4.69 | 6.33 | 4.84 |
| ROA(%) | 0.8 | 6.67 | 1.39 | 3.15 | 5.16 | 3.23 |
| ROE(%) | 1.88 | 17.76 | 4.09 | 8.36 | 11.05 | 6.46 |
| ROCE(%) | 6.01 | 13.22 | 6.87 | 10.6 | 14.62 | 9.82 |
| Receivable days | 20.07 | 28.35 | 34.53 | 36.37 | 41.91 | 40.53 |
| Inventory Days | 63.27 | 50.81 | 46.94 | 46.18 | 54.62 | 64.67 |
| Payable days | 28.4 | 50.56 | 59.4 | 48.93 | 50.8 | 54.49 |
| PER(x) | 0 | 32.68 | 103.67 | 28.33 | 21.96 | 23.32 |
| Price/Book(x) | 0 | 5.33 | 4.19 | 2.14 | 2.15 | 1.46 |
| Dividend Yield(%) | 0 | 0.32 | 0 | 0 | 0 | 0.25 |
| EV/Net Sales(x) | 0.36 | 1.83 | 1.27 | 0.83 | 0.95 | 0.68 |
| EV/Core EBITDA(x) | 4.89 | 18.71 | 22.5 | 10.43 | 8.98 | 9.84 |
| Net Sales Growth(%) | 0 | 42.93 | 23.56 | 4.48 | -1.9 | 11.74 |
| EBIT Growth(%) | 0 | 152.21 | -40.08 | 63.05 | 41.84 | -30.22 |
| PAT Growth(%) | 0 | 937.08 | -74.6 | 131.21 | 67.87 | -31.8 |
| EPS Growth(%) | 0 | 937.08 | -74.6 | 124.19 | 57.47 | -31.74 |
| Debt/Equity(x) | 0.98 | 1.15 | 1.19 | 0.89 | 0.45 | 0.47 |
| Current Ratio(x) | 0.99 | 1.07 | 1.17 | 1.28 | 1.54 | 1.35 |
| Quick Ratio(x) | 0.4 | 0.62 | 0.67 | 0.74 | 0.78 | 0.63 |
| Interest Cover(x) | 1.29 | 3.19 | 1.87 | 2.2 | 3.29 | 2.79 |
| Total Debt/Mcap(x) | 0 | 0.21 | 0.28 | 0.39 | 0.21 | 0.32 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 49.81 | 49.81 | 49.81 | 49.92 | 49.92 | 49.92 | 49.92 | 49.92 | 49.88 | 49.87 |
| FII | 0.04 | 0.09 | 0.04 | 0.06 | 0 | 0.14 | 0 | 0 | 0 | 0.14 |
| DII | 0.02 | 0.01 | 0.01 | 1.07 | 0.81 | 0.81 | 0.81 | 0.81 | 0.31 | 0.01 |
| Public | 50.14 | 50.09 | 50.14 | 48.95 | 49.28 | 49.14 | 49.28 | 49.28 | 49.81 | 49.98 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 |
| Public | 0.43 | 0.42 | 0.43 | 0.41 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.85 | 0.85 | 0.85 | 0.85 | 0.85 | 0.85 | 0.85 | 0.85 | 0.85 | 0.85 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.